Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus, Human”

521 trials

Showing 20 of 521 results

Early research (Phase 1)Ended earlyNCT02460016
What this trial is testing

AK0529 in Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT07128121
What this trial is testing

Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus (RSV) Infection
Shenzhen Shenxin Biotechnology Co., Ltd 500
Post-approval studies (Phase 4)Active Not RecruitingNCT06551506
What this trial is testing

The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 181
Not applicableStudy completedNCT06185647
What this trial is testing

Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

Who this might be right for
BronchiolitisRespiratory Syncytial Virus (RSV)Immunization; Infection
Hôpital Armand Trousseau 4,924
Not applicableUnknownNCT04288921
What this trial is testing

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Who this might be right for
Influenza, HumanRespiratory Syncytial Virus Infections
LumiraDx UK Limited 2,000
Not applicableStudy completedNCT02273882
What this trial is testing

An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants

Who this might be right for
Respiratory Syncytial Virus Hospitalizations
AstraZeneca 497
Testing effectiveness (Phase 2)Study completedNCT03691623
What this trial is testing

A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 179
Not applicableUnknownNCT03621930
What this trial is testing

RESCEU Study, Defining the Burden of Disease of RSV in Older Adults

Who this might be right for
RSV InfectionRespiratory Syncytial Virus InfectionsBronchiolitis
UMC Utrecht 1,040
Early research (Phase 1)Study completedNCT02114268
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 342
Large-scale testing (Phase 3)Study completedNCT04231968
What this trial is testing

AK0529 in Chinese Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 311
Testing effectiveness (Phase 2)Active Not RecruitingNCT06143046
What this trial is testing

MRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 360
Early research (Phase 1)Active Not RecruitingNCT06216093
What this trial is testing

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

Who this might be right for
Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus (RSV)
EuBiologics Co.,Ltd 100
Early research (Phase 1)Study completedNCT02237209
What this trial is testing

Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 29
Testing effectiveness (Phase 2)Study completedNCT04816721
What this trial is testing

Evaluate EDP 938 Regimens in Children With RSV

Who this might be right for
Respiratory Syncytial Virus (RSV)
Enanta Pharmaceuticals, Inc 99
Not applicableStudy completedNCT06424795
What this trial is testing

Molecular and Microbiome/Metagenome Correlates of Recurrent Wheeze in RSV Infected Infants

Who this might be right for
Respiratory Syncytial Virus Infection
University of Rochester 100
Not applicableStudy completedNCT03574532
What this trial is testing

Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)

Who this might be right for
Respiratory Tract Infections
Janssen-Cilag International NV 118
Not applicableLooking for participantsNCT06180993
What this trial is testing

Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization

Who this might be right for
RSV Infection
Federico Martinón Torres 42,000
Testing effectiveness (Phase 2)Study completedNCT03636906
What this trial is testing

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 201
Early research (Phase 1)Study completedNCT01459198
What this trial is testing

Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT02282982
What this trial is testing

Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis

Who this might be right for
Respiratory Syncytial Virus (RSV)
AbbVie 359
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation